If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.75    0.00 (0.00%)
Bid:
2.50
Ask:
3.00
Spread: 0.50 (20.00%)
Market Cap: £19.93m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Director/PDMR Shareholding

30 Mar 2010 15:21

RNS Number : 4454J
Amphion Innovations PLC
30 March 2010
 



 

 

Amphion Innovations plc

Director Shareholding

 

 

London and New York, 30 March 2010 - Amphion Innovations plc (LSE: AMP) (the "Company" or "Amphion") was advised, on 29 March 2010 that Richard Morgan, CEO of Amphion, purchased 50,000 ordinary shares at 15 pence per ordinary shares on 23 March 2010 in the Company and 15,000 ordinary shares at 16 pence per ordinary share on 25 March 2010.

 

Accordingly, Richard Morgan is now beneficially interested in 23,792,499 ordinary shares, representing 17.967 per cent of its issued ordinary share capital.

 

For further information please contact:

 

Amphion Innovations

Charlie Morgan:

+1 (212) 210-6224

 

Charles Stanley Securities, Nominated Advisor

Mark Taylor:

+44 020 7149 6000

 

Cardew Group

Tim Robertson/ Jamie Milton/Daniela Cormano:

+44 020 7930 0777

 

On the web: www.amphionplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZBLFXBXFLBBB
Date   Source Headline
24th Sep 20107:00 amRNSIP Licensing
22nd Sep 20108:00 amRNSGrant Win by Partner Company Firestar
10th Sep 20107:00 amRNSHalf Yearly Report
8th Sep 20107:00 amRNSIssue of Equity
2nd Aug 20102:54 pmRNSTotal Voting Rights
30th Jun 20107:00 amRNSIssue of Equity
29th Jun 20107:00 amRNSPartner Company Kromek acquires US Company
8th Jun 20107:00 amRNSAGM Statement
18th May 20107:00 amRNSDirector/PDMR Shareholding
30th Mar 20103:21 pmRNSDirector/PDMR Shareholding
16th Mar 20107:00 amRNSFinal Results
15th Mar 20107:00 amRNSPartner Company Kromek Completes Fundraising
8th Mar 20107:00 amRNSNotice of Results
2nd Feb 20107:00 amRNSTrading Update
6th Jan 20107:00 amRNSDirector/PDMR Shareholding
23rd Dec 20097:01 amRNSFunding & IP Licensing Updates
25th Nov 20097:00 amRNSAmphion Partnership with Kuwait University
30th Oct 20095:11 pmRNSTotal Voting Rights
16th Oct 20092:37 pmRNSDirector/PDMR Shareholding
6th Oct 20098:59 amRNSPartner Company Wellgen Release
21st Sep 20092:41 pmRNSDirector/PDMR Shareholding
20th Aug 20097:00 amRNSHalf Yearly Report
25th Jun 20097:00 amRNSIP License Agreements
4th Jun 20097:00 amRNSAGM Statement
14th May 20095:26 pmRNSAnnual Financial Report
13th May 20095:29 pmRNSIssue of Equity
5th May 20097:00 amRNSIP License Agreements
1st May 20097:00 amRNSDirectorate Change
30th Apr 20095:05 pmRNSTotal Voting Rights
7th Apr 20093:54 pmRNSDirector/PDMR Shareholding
26th Mar 20093:47 pmRNSDirector/PDMR Shareholding
16th Mar 20097:00 amRNSFinal Results
4th Mar 200910:51 amRNSNotice of Results
27th Feb 20094:46 pmRNSDirector Dealings
27th Feb 20091:20 pmRNSAmphion Partner AXCESS International Wins Contract
30th Jan 20097:00 amRNSFunding Update
19th Jan 20097:00 amRNSTrading Statement
31st Dec 20087:00 amRNSConvertible Promisory Note Offering
27th Nov 20087:00 amRNSPartner Company Announces IP License Agreement
31st Oct 20083:46 pmRNSTotal Voting Rights
28th Oct 20087:00 amRNSNew CEO for Partner Company
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
17th Oct 20087:00 amRNSPartner Company Announces IP Licence Agreement
17th Sep 20087:00 amRNSPartner Company - Product Launch
16th Sep 20087:14 amRNSDirector/PDMR Shareholding
18th Aug 20087:00 amRNSInterim Results
1st Aug 20089:00 amRNSNotice of Interim Results
17th Jun 20082:54 pmRNSDirector/PDMR Shareholding
12th Jun 20087:00 amRNSAGM Statement
10th Jun 20087:00 amRNSPartner Company Announces IP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.